The Effect of Blue-light Filtering Spectacle Lenses on Myopia Progression in Schoolchildren

Sponsor
The Hong Kong Polytechnic University (Other)
Overall Status
Completed
CT.gov ID
NCT03538002
Collaborator
(none)
148
1
2
38.7
3.8

Study Details

Study Description

Brief Summary

The purpose of this study is to investigate if the blue-light filtering spectacle lenses promote myopia progression in schoolchildren.

Condition or Disease Intervention/Treatment Phase
  • Device: Blue-light filtering spectacle lenses
N/A

Detailed Description

The effect of blue light on ocular health has been studied extensively. Shorter wavelength such as blue light could cause damage to the retina. The damage was more evident in the ageing eye. Since the tablets and mobile with blue LED backlight display are widely used, thus blue-light filtering spectacle lenses are now available in the market. However, whether this kind of lenses could affect the eye growth in schoolchildren is unknown. This study is then designed to investigate if the blue-light filtering spectacle lenses affect myopia progression in Hong Kong Chinese schoolchildren. The schoolchildren will be randomly allocated to either blue-light filtering spectacle lens group (treated) or conventional spectacle lens group (control). Their axial length and refraction will be monitored every 6 months for 2 years. The changes between two group will then be compared.

Study Design

Study Type:
Interventional
Actual Enrollment :
148 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Does Blue-light Filtering Spectacle Lens Promote Myopia Progression in Schoolchildren
Actual Study Start Date :
Sep 10, 2018
Actual Primary Completion Date :
Nov 30, 2021
Actual Study Completion Date :
Nov 30, 2021

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Conventional anti-reflection coated spectacle lens

Single vision lenses with correction of distant refraction and conventional anti-reflection coating

Experimental: Blue-light filtering spectacle lenses

Single vision lenses with correction of distant refraction and blue-light filtering coating

Device: Blue-light filtering spectacle lenses
This is a single vision spectacle lens for correction of distant refractions and filtering out the blue light by providing anti-blue light coating.

Outcome Measures

Primary Outcome Measures

  1. Cycloplegic refraction [2 years]

    Refraction done under cycloplegia

Secondary Outcome Measures

  1. Axial length [2 years]

    Length of eyeball that is directly related to myopia

Eligibility Criteria

Criteria

Ages Eligible for Study:
8 Years to 13 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Refraction: myopia of -1.00 dioptres (D) to -5.00D

  • Astigmatism: equal or less than -1.50D

  • Anisometropia: equal or less than 1.00D

  • Best corrected monocular visual acuity: 0.0 LogMAR or better after full correction

  • Parents' understanding and acceptance of random allocation of grouping

Exclusion Criteria:
  • any ocular and systemic abnormalities might affect visual functions or refractive development

  • prior treatment of myopic control, e.g. drugs, orthokeratology, progressive addition lenses, bifocal lenses, drugs (e.g. atropine), etc.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre of Myopia Research, School of Optometry, The Hong Kong Polytechnic University Hong Kong Hong Kong 00000

Sponsors and Collaborators

  • The Hong Kong Polytechnic University

Investigators

  • Principal Investigator: Ka Man Chun, PhD, Centre for Myopia Research, The Hong Kong Polytechnic University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
The Hong Kong Polytechnic University
ClinicalTrials.gov Identifier:
NCT03538002
Other Study ID Numbers:
  • 05161146
First Posted:
May 25, 2018
Last Update Posted:
Jan 13, 2022
Last Verified:
Jan 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by The Hong Kong Polytechnic University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 13, 2022